American Heart Journal

Papers
(The H4-Index of American Heart Journal is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms214
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study188
Table of Contents101
Table of Contents97
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF91
Editorial Board74
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes66
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network57
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network55
Information for Readers44
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function41
The trial to assess chelation therapy 2 (TACT2): Rationale and design39
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients38
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial38
Information for Readers35
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER35
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer33
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease33
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig31
Cardiac auscultation skills among medical trainees31
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e30
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States30
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial30
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study29
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings28
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections28
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism28
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial27
0.10137009620667